On the basis of the clinical evidence for the negative association of the prescription of ACEIs and ARBs, but not CaBs, with DPN development in the above-described retrospective cohort study, we conducted a reverse translational analysis using leptin-deficient ob/ob mice, a model for T2DM. This evidence concerns the gene LEP and type 2 diabetes mellitus.